Advertisement

More articles from Large Molecule Therapeutics

  • Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody
    Tatsushi Kodama, Yu Kochi, Waka Nakai, Hideaki Mizuno, Takeshi Baba, Kiyoshi Habu, Noriaki Sawada, Hiroyuki Tsunoda, Takahiro Shima, Kohta Miyawaki, Yoshikane Kikushige, Yasuo Mori, Toshihiro Miyamoto, Takahiro Maeda, Koichi Akashi
    Molecular Cancer Therapeutics Jul 2019, DOI: 10.1158/1535-7163.MCT-18-1216
  • MEN1309/OBT076 Causes Complete Responses in Tumor Xenografts
    Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, Alessandro Bressan, Corrado Carrisi, Daniela Bellarosa, Massimiliano Salerno, Rossana Bugianesi, Rosanna Manno, Cristina Bernadó Morales, Joaquin Arribas, Rachel L. Dusek, James E. Ackroyd, Phuoc Huy Pham, Rahel Awdew, Dee Aud, Michael Trang, Carmel M. Lynch, Jonathan Terrett, Keith E. Wilson, Christian Rohlff, Stefano Manzini, Andrea Pellacani, Monica Binaschi
    Molecular Cancer Therapeutics Jun 2019, DOI: 10.1158/1535-7163.MCT-18-0624
  • A SOX9 Peptide Inhibits the Oncogenic Wnt/β-Catenin Pathway
    Philippe Blache, Lucile Canterel-Thouennon, Muriel Busson, Pascal Verdié, Gilles Subra, Marc Ychou, Corinne Prévostel
    Molecular Cancer Therapeutics Aug 2019, 18 (8) 1386-1395; DOI: 10.1158/1535-7163.MCT-18-1149
  • A Novel Fully Human PSMA Antibody Inhibits PCa Tumor Growth
    Jieheng Wu, Donghui Han, Shengjia Shi, Qiang Zhang, Guoxu Zheng, Ming Wei, Yueheng Han, Guodong Li, Fa Yang, Dian Jiao, Pin Xie, Lingling Zhang, An-Gang Yang, Aizhi Zhao, Weijun Qin, Weihong Wen
    Molecular Cancer Therapeutics Jul 2019, 18 (7) 1289-1301; DOI: 10.1158/1535-7163.MCT-18-1078
  • Trifunctional Antibody-IL15/scTNFSF Fusion Proteins
    Nadine Beha, Markus Harder, Sarah Ring, Roland E. Kontermann, Dafne Müller
    Molecular Cancer Therapeutics Jul 2019, 18 (7) 1278-1288; DOI: 10.1158/1535-7163.MCT-18-1204
  • Peptide Nanoparticle Vaccine for Antitumor Immunotherapy
    Carolin Heße, Sebastian Kollenda, Olga Rotan, Eva Pastille, Alexandra Adamczyk, Christina Wenzek, Wiebke Hansen, Matthias Epple, Jan Buer, Astrid M. Westendorf, Torben Knuschke
    Molecular Cancer Therapeutics Jun 2019, 18 (6) 1069-1080; DOI: 10.1158/1535-7163.MCT-18-0764
  • Effect of EGFR-ADC SHR-A1307 in Drug-Resistant Cancer
    Kaijie He, Jianyan Xu, Jindong Liang, Jiahua Jiang, Mi Tang, Xin Ye, Zhebin Zhang, Lei Zhang, Beibei Fu, Yan Li, Chang Bai, Lianshan Zhang, Weikang Tao
    Molecular Cancer Therapeutics Jun 2019, 18 (6) 1104-1114; DOI: 10.1158/1535-7163.MCT-18-0854
  • Peptide Antagonist of PD-1 Signaling Pathway
    Pottayil G. Sasikumar, Raghuveer K. Ramachandra, Srinivas Adurthi, Amit A. Dhudashiya, Sureshkumar Vadlamani, Koteswararao Vemula, Sriharibabu Vunnum, Leena K. Satyam, Dodderi S. Samiulla, Krishnaprasad Subbarao, Rashmi Nair, Rajeev Shrimali, Nagaraj Gowda, Murali Ramachandra
    Molecular Cancer Therapeutics Jun 2019, 18 (6) 1081-1091; DOI: 10.1158/1535-7163.MCT-18-0737
  • Amplified Tumor Uptake by a Guide-effector Bispecific Design
    Nam-Kyung Lee, Yang Su, Scott Bidlingmaier, Bin Liu
    Molecular Cancer Therapeutics Jun 2019, 18 (6) 1092-1103; DOI: 10.1158/1535-7163.MCT-18-1313
  • EP-100 Sensitizes Ovarian Cancer Cells to Olaparib
    Shaolin Ma, Sunila Pradeep, Alejandro Villar-Prados, Yunfei Wen, Emine Bayraktar, Lingegowda S. Mangala, Mark Seungwook Kim, Sherry Y. Wu, Wei Hu, Cristian Rodriguez-Aguayo, Carola Leuschner, Xiaoyan Liang, Prahlad T. Ram, Katharina Schlacher, Robert L. Coleman, Anil K. Sood
    Molecular Cancer Therapeutics May 2019, 18 (5) 969-979; DOI: 10.1158/1535-7163.MCT-18-0770

Pages